Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases

  • Godoy, Pere|||0000-0002-2896-7286
  • Soldevila, Núria|||0000-0002-1353-5325
  • Martínez, Ana Isabel
  • Godoy, Sofía
  • Jané i Checa, Mireia|||0000-0002-1302-6723
  • Torner, Núria
  • Acosta Argueta, Lesly María|||0000-0002-5859-2120
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Domínguez, Àngela
Introduction: Influenza vaccination may be effective in preventing influenza infection and may reduce the risk of influenza-associated pneumonia. The study aim was to evaluate the effect of influenza vaccination in preventing pneumonia when it failed to prevent influenza hospitalization. Methods: This was a case-control study comparing hospitalized cases of influenza with and without pneumonia in patients aged ≥18 years in 16 hospitals in Catalonia over 10 influenza seasons (2010-11 to 2019-20). Data on sociodemographic, virological characteristics, comorbidities, vaccination history, and antiviral treatment were collected and analysed. The crude odds ratio (OR) and adjusted OR (aOR) with the corresponding 95% confidence interval (CI) values were calculated. Results: In total, 5080 patients hospitalized for severe influenza were included, 63.5% (3224/5080) of whom had pneumonia-mostly men (56.8%; 1830/3224) and mostly in the ≥75 age group (39.3%; 1267/3224)-and of whom 14.0% died (451/3224). Virus A and virus B accounted for 78.1% (2518/3224) and 21.9% (705/3224) of influenza types, respectively. Starting antiviral treatment ≤48 h after symptom onset (aOR = 0.69; 95%CI: 0.53-0.90) and a history of seasonal influenza vaccination (aOR = 0.85; 95%CI: 0.72-0.98) were protective factors in developing pneumonia. Conclusions: Adherence to seasonal influenza vaccination and starting antiviral treatment within 48 h of symptom onset can reduce pneumonia risk in severe influenza cases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Vaccinated COVID-19 Index Cases Are Less Likely to Transmit SARS-CoV-2 to Their Household Contacts, A Cohort Study

  • Godoy, Pere|||0000-0002-2896-7286
  • Martínez-Baz, Iván|||0000-0002-3405-2277
  • Parrón, Ignacio|||0000-0002-4875-0236
  • García Cenoz, Manuel|||0000-0001-7316-9104
  • Ferras, Joaquim
  • Carol, Mònica
  • Bes, Nuria
  • Guillaumes, Montserrat|||0009-0008-2827-8836
  • Godoy, Sofia
  • Toledo, Diana|||0000-0003-0794-9238
  • Follia, Núria
  • Miret, Carme|||0000-0001-6154-3998
  • Pardos, Jessica
  • Alsedà, Miquel|||0000-0003-4008-3616
  • Plans-Rubió, Pedro|||0000-0002-4424-2971
  • Sanz, Inma
  • Sala-Farré, Maria Rosa
  • Caylà, Joan A.|||0000-0003-3891-111X
  • Mendioroz Peña, Jacobo|||0000-0002-8883-2180
  • Muñoz-Almagro, Carmen|||0000-0001-5586-404X
  • Castilla, Jesus|||0000-0002-6396-7265
  • Domínguez, Ángela|||0000-0003-0219-1907
The aim of this study was to evaluate the impact of index case vaccination on SARS-CoV-2 transmission to household contacts. In our epidemiological cohort study (May 2022-November 2023), we surveyed registered index case vaccination status and test results for contacts (testing on day 0, and on day 7 for negative contacts) and calculated the secondary attack rate (SAR), i.e., newly infected contacts/susceptible included contacts. The association of the independent variable, index case COVID-19 vaccination (yes/no), with household contact infection was determined using the adjusted odds ratio (aOR) and its 95% confidence interval (CI). We recorded 181 index cases and 314 contacts, of whom 250 agreed to participate; 16 contacts were excluded upon testing positive on day 0. Of the 234 included contacts, 49.1% were women, and the mean (SD) age was 51.9 (19.8) years. The overall SAR of 37.2% (87/234) was lower in the contacts of both vaccinated index cases (34.9% vs. 63.2%; p = 0.014) and index cases with a previous SARS-CoV-2 infection history (27.0% vs. 46.3%; p = 0.002). Index case vaccination showed a protective effect against infection for their household contacts (aOR = 0.21; 95% CI: 0.07, 0.67). The household SAR was high when the Omicron variant circulated. Vaccinated index cases were less likely to transmit SARS-CoV-2 to their contacts.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations

  • Godoy, S.
  • Alsedà, Miquel|||0000-0003-4008-3616
  • Parrón, Ignacio|||0000-0002-4875-0236
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Caylà, Joan A.|||0000-0003-3891-111X
  • Follia, Núria
  • Carol, Monica
  • Orcau, Àngels|||0000-0001-8109-7614
  • Toledo, Diana|||0000-0003-0794-9238
  • Ferrús, Glòria
  • Plans, Pere
  • Barrabeig, Irene|||0000-0003-4789-7620
  • Clotet Romero, Laura|||0000-0001-9522-7870
  • Domínguez, Ángela|||0000-0003-0219-1907
  • March-Llanes, Jaume|||0000-0002-5977-8744
  • Godoy, Pere|||0000-0002-2896-7286
Background: Exposure time to a tuberculosis (TB) index case may be a marker of a recent latent tuberculosis infection (LTBI) risk. The aim of this study was to determine the LTBI risk involved in immigrant contact based on exposure time to pulmonary TB index cases. Methods: We conducted a 30-month LTBI prevalence study of pulmonary TB immigrant contacts in Catalonia (1 January 2019-30 June 2021). Contacts with LTBI were identified by means of the tuberculin skin test and/or interferon gamma release assay. Variables associated with LTBI in contacts were analysed using adjusted OR (aOR) and 95% confidence interval (CI) values. Results: LTBI prevalence was 37.4% (939/2509). Prevalence was higher in men than women (40.6% versus 33.5%; p < 0.001), and in all age groups, relative to children <5 years (12.2%; p < 0.001)). Prevalence increased with exposure time to the index case; relative to <6 h/week exposure, LTBI risk was greater for both ≥6 h/day (aOR = 2.0; 95% CI: 1.5-2.6) and <6 h/day but ≥6 h/week (aOR = 1.6; 95% CI: 1.1-2.2). Conclusions: The LTBI risk in immigrant contacts increases with recent exposure time to the index case, and may suggest recent LTBI in immigrants.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Documented vaccination as proof of immunity compared to serology in medical students

  • Godoy, Pere|||0000-0002-2896-7286
  • Toledo, Diana|||0000-0003-0794-9238
  • Casas, Irma|||0000-0002-5902-5777
  • Colmenares, Karen
  • Vilella, Anna|||0000-0002-2329-676X
  • Prat, Andreu
  • Mormeneo-Bayo, Saray|||0000-0003-2586-1539
  • Bartolomé Comas, Rosa Maria|||0000-0001-7655-6089
  • Ibarz Escuer, Mercedes|||0000-0003-0590-946X
  • Domínguez, Ángela|||0000-0003-0219-1907
We analyzed immunity to vaccine-preventable diseases and the predictive value of documented vaccination versus serological results for medical students in Catalonia (Spain). Epidemiological study of antibody seroprevalence and vaccination in medical students at four teaching units of medicine. Blood samples were drawn from participants who completed an epidemiology questionnaire. For seven diseases, we calculated the positive predictive value (PPV) percentages (and 95% CI) reflecting the protection afforded by self-reported vaccination histories compared to serology results. We enrolled 146 medical students (participation 25.7%; 146/569), 79.5% (116/146) women, mean (SD) age 22.6 (1.6) years. Most students (84.2%; 123/146) were fully vaccinated, 18 were unaware of their vaccination status, and 5 students were not vaccinated. Of the six overseas students, only three could document their vaccination status (OR = 6.0; 95% CI: 1.1-31.8). In documented vaccination terms, PPVs for immunological protection were high for varicella (100%), COVID-19 (99.1%), hepatitis A (98.9%), and rubella (94.8%), but was substantially lower for measles (90.0%), mumps (85.9%), and hepatitis B (67.2%). The predictive value of documented vaccination history compared to serology as proof of immunity was above 90% for most vaccines except for measles, mumps, and hepatitis B. OrderedDict([(u'list', OrderedDict([(u'@list-type', u'bullet'), (u'@id', u'list_0001'), (u'list-item', [OrderedDict([(u'p', u'Documented vaccination as immunity evidence was studied for seven vaccine-preventable diseases.')]), OrderedDict([(u'p', u'Positive predictive values were just 90.0% for measles, 85.9% for mumps, and 67.2% for hepatitis B.')]), OrderedDict([(u'p', u'To administer booster doses as necessary, documented vaccination for measles, mumps, and hepatitis B should be contrasted with serology results.')])])]))]).